NeutriSci International Inc. (CVE:NU), a nutraceutical stock, surged after announcing a joint venture with Lexaria Bioscience Corp. to develop cannabinoid sublingual tablets
Sean Mason | April 10, 2017 | SmallCapPower
A potential move into cannabinoid products generated much interest in a nutraceutical stock Monday. Here’s some small stocks making big moves on Monday, April 10, 2017 (as of 4 pm EST):
Nutraceutical stock NeutriSci International Inc. (TSXV: NU) powered 16% higher to $0.145 on Monday after announcing the finalization of the joint venture with Lexaria Bioscience Corp. to produce and commercialize a line of healthy, sugar-free, edible cannabinoid sublingual tablets combining NeutriSci’s proprietary pterostilbene tablet form factor and Lexaria’s patented technology.
As well, shares of Opawica Explorations Inc. (TSXV: OPW) sank 37% to $0.06 as the junior explorer released drill results from its 100% owned Bazooka East gold property in Quebec, which included 54.8 metres of 0.65 grams per tonne (g/t) gold.
Identillect Technologies Corp. (TSXV: ID), meanwhile, reported that it has achieved double-digit subscriber growth over the past two quarters, driven by the adoption of Identillect’s Delivery Trust email encryption solution by new customers. Identillect Technologies stock moved up 15% to $0.15 following the announcement.
Finally, Trilogy Metals Inc. (TSX: TMQ) shares jumped 23% to $0.92 after the metals exploration company announced that it has granted South32 Limited an option to form a 50/50 joint venture with respect to Trilogy’s Alaskan assets. To earn the 50% interest, South32 will contribute a minimum of US$150 million, plus any amounts Trilogy spends at the Arctic Project over the next three years to a maximum of US$5 million per year.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
